X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (950) 950
Publication (66) 66
Book Review (21) 21
Book / eBook (4) 4
Magazine Article (4) 4
Book Chapter (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (846) 846
male (548) 548
index medicus (517) 517
gout suppressants - therapeutic use (507) 507
gout - drug therapy (436) 436
gout (410) 410
gout suppressants - administration & dosage (389) 389
female (377) 377
middle aged (336) 336
hyperuricemia (304) 304
allopurinol (286) 286
aged (285) 285
gout suppressants - adverse effects (281) 281
uric acid - blood (261) 261
adult (259) 259
rheumatology (243) 243
treatment outcome (206) 206
pharmacology & pharmacy (194) 194
hyperuricemia - drug therapy (188) 188
febuxostat (185) 185
allopurinol - therapeutic use (179) 179
management (173) 173
colchicine (172) 172
colchicine - therapeutic use (151) 151
uric acid (146) 146
colchicine - administration & dosage (142) 142
allopurinol - administration & dosage (133) 133
arthritis (131) 131
animals (129) 129
care and treatment (127) 127
medicine, general & internal (126) 126
gout suppressants - pharmacology (117) 117
allopurinol - adverse effects (115) 115
dose-response relationship, drug (114) 114
gout - blood (113) 113
aged, 80 and over (105) 105
risk factors (99) 99
drug therapy (92) 92
xanthine oxidase - antagonists & inhibitors (87) 87
uric-acid (85) 85
colchicine - adverse effects (79) 79
arthritis, gouty - drug therapy (78) 78
abridged index medicus (77) 77
analysis (77) 77
acute disease (75) 75
gout - diagnosis (74) 74
gout suppressants - pharmacokinetics (73) 73
medicine & public health (73) 73
retrospective studies (73) 73
anti-inflammatory agents, non-steroidal - therapeutic use (71) 71
hyperuricemia - blood (71) 71
internal medicine (71) 71
gout - complications (70) 70
risk (70) 70
therapy (69) 69
disease (68) 68
double-blind (68) 68
rheumatism (68) 68
drug therapy, combination (66) 66
serum urate (66) 66
time factors (64) 64
dosage and administration (63) 63
research (63) 63
serum uric-acid (61) 61
young adult (61) 61
thiazoles - therapeutic use (59) 59
administration, oral (55) 55
drug administration schedule (55) 55
urate (55) 55
follow-up studies (54) 54
adolescent (53) 53
chronic disease (53) 53
gout - epidemiology (51) 51
inflammation (51) 51
urate oxidase - therapeutic use (50) 50
hyperuricemia - complications (49) 49
thiazoles - administration & dosage (49) 49
diagnosis (48) 48
double-blind method (47) 47
prevention (47) 47
rats (47) 47
uric acid - metabolism (47) 47
efficacy (46) 46
oxidases (45) 45
health aspects (44) 44
mice (44) 44
drug interactions (43) 43
prevalence (42) 42
drug dosages (41) 41
epidemiology (41) 41
pharmacokinetics (41) 41
purines (40) 40
thiazoles - adverse effects (40) 40
gout - physiopathology (39) 39
hypertension (39) 39
of-rheumatology guidelines (39) 39
rasburicase (39) 39
safety (39) 39
patients (38) 38
urate oxidase - administration & dosage (38) 38
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (889) 889
German (21) 21
French (16) 16
Danish (7) 7
Japanese (7) 7
Russian (5) 5
Dutch (3) 3
Spanish (3) 3
Chinese (2) 2
Hungarian (2) 2
Italian (2) 2
Czech (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Rheumatology (Oxford, England), ISSN 1462-0324, 12/2014, Volume 53, Issue 12, pp. 2167 - 2174
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 07/2011, Volume 70, Issue 7, pp. 1264 - 1271
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9760, pp. 165 - 177
Summary The approval of febuxostat, a non-purine-analogue inhibitor of xanthine oxidase, by the European Medicines Agency and the US Food and Drug... 
Internal Medicine | URATE OXIDASE | MEDICINE, GENERAL & INTERNAL | SERUM URATE | XANTHINE-OXIDASE | PEGLOTICASE PGL THERAPY | DOUBLE-BLIND | PURINE SELECTIVE INHIBITOR | EVIDENCE BASED RECOMMENDATIONS | FEBUXOSTAT TMX-67 | ASPERGILLUS-FLAVUS | TREATMENT-FAILURE GOUT | Recombinant Fusion Proteins - pharmacology | Urate Oxidase - pharmacology | United States | Humans | Gout - drug therapy | Thiazoles - administration & dosage | Drug Approval | Thiazoles - adverse effects | Interleukin 1 Receptor Antagonist Protein - pharmacology | Interleukin-1 - antagonists & inhibitors | United States Food and Drug Administration | Xanthine Oxidase - antagonists & inhibitors | Polyethylene Glycols - pharmacology | Uric Acid - metabolism | Drug Administration Schedule | Febuxostat | Antibodies, Monoclonal - pharmacology | Europe | Enzyme Inhibitors - pharmacology | Clinical Trials as Topic | Gout Suppressants - adverse effects | Randomized Controlled Trials as Topic | Gout Suppressants - administration & dosage | Gout - metabolism | Uricosuric Agents - pharmacology | Gout Suppressants - pharmacology | Thiazoles - pharmacology | Drug therapy | Gout | Cardiovascular disease | Heart attacks | Metabolites | Primary care | Urate oxidase | Crystals | Clinical trials | Data processing | Inflammation | Proximal tubules | Uric acid | Drug development | Kidney | Reviews | Interleukin 1 | Xanthine oxidase
Journal Article
Clinical & Experimental Allergy, ISSN 0954-7894, 11/2013, Volume 43, Issue 11, pp. 1246 - 1255
Journal Article